Amedisys (AMED) Tops Q3 EPS by 2c, Miss on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys (AMED) Tops Q3 EPS by 2c, Miss on Revenues

Amedisys (AMED) PT Raised to $64 at Jefferies

November 8, 2017 8:35 AM EST

Jefferies raised its price target on Amedisys (NASDAQ: AMED) to $64.00 (from $60.00) while maintaining a Buy rating following Q3.

Analyst Brian Tanquilut said the 5% SS increase in Medicare episodes highlights early traction the company is seeing with its revamped sales force and growth initiatives.

... More